Obermatt

WuXi AppTec

SHH:603259 · CNE1000031K4
Life Sciences Tools & ServicesX-Large

360

99
EV / EBIT92
Price / Owner Earnings60
Owner Earnings Yield99
Dividend Yield49
Price/Sales3
EV / Gross Profit29
Price/Book10
Return on Capital95
Cash Return on Capital91
Return on Equity94
EBIT Margin97
Gross Profitability61
Cash Conversion8
Accruals3
Owner Earnings Margin99
Sales growth87
Profit Growth95
Long-Term EPS Growth85
Owner Earnings Growth85
Reinvestment73
Price momentum87
Debt load73
Refinancing33
Debt Payback100
Liquidity82
Analyst ratings90
Opinion Changes50
Price Target Upside93
Market mood1
Value Creation18/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

WuXi AppTec generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryChina
IndustryLife Sciences Tools & Services
SizeX-Large
TypePublic Company
ExchangeSHSE
Founded2017
Employees1,869
ISINCNE1000031K4
Last UpdateApr 2, 2026
Themes
Stem Cell TherapyGeneticsHealth DiagnosticsBiomedical EngineeringBiotechnologyHealth CareProfessional ServicesScience and Engineering

Description

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies. Business Segments The company operates through busine…

Analysis

Middle-of-the-road

WuXi AppTec Co., Ltd. sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is fair. The owner-earnings multiple stands at 17.9×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 5% a year, against analyst forecasts of 22%. The price, in other words, assumes less than the experts do.

Growth is solid; the safety picture is sturdy. The company scores 18/20 on our value-creation score: strong value creator.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
43
2026

All-time high

86

Feb 2026

All-time low

43

Mar 2026

Average rank

65

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
3
Price/Earnings
30
Price/Book
10
Dividend Yield
49
Value (overall)
8

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare WuXi AppTec with its peers
Rohto Pharmaceutical
TYO:4527
81
CountryJapan
IndustryPersonal Products
SizeLarge
Full Stock Analysis →
WuXi Biologics (Cayman)
HKG:2269
87
CountryHong Kong SAR China
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Alfresa Holdings
TYO:2784
70
CountryJapan
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
JW
KSC:096760
97
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Suzuken
TYO:9987
60
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Tsuruha Holdings
TYO:3391
91
CountryJapan
IndustryFood & Staples Retailing
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →